Team
health

Iron Deficiency Calculator

Iron deficiency anemia affects millions globally, particularly women and those with chronic illness. Clinicians need to calculate precise iron replacement doses to avoid under- or over-treatment. This calculator applies the Ganzoni equation—the gold standard in clinical practice—to determine total iron deficit based on patient weight, current hemoglobin, and target hemoglobin concentration. Results guide decisions between oral supplementation and intravenous iron infusion.

Last updated:

Creators Małgorzata Koperska, MD
2,097 people find this calculator helpful

How to Use This Calculator

Enter the patient's weight in kilograms. For overweight patients (BMI >25), use ideal body weight; for underweight patients (BMI <18.5), use actual weight. This distinction matters because the Ganzoni calculation assumes normal body composition.

Input the patient's current hemoglobin level in g/dL—the calculator accepts either unit system seamlessly. Set your target hemoglobin based on sex and clinical context: women typically target 12–15.5 g/dL, men 13.5–17.5 g/dL. The calculator automatically sets iron stores based on weight (minimum 500 mg for patients ≥35 kg, or 15 mg/kg for lighter individuals).

The result shows total iron deficit in milligrams. This figure determines whether oral iron therapy (smaller deficits, better tolerated) or intravenous iron infusion (larger deficits, faster repletion) is appropriate.

The Ganzoni Equation

The Ganzoni formula remains the most widely adopted method in clinical hematology for calculating iron replacement therapy. It accounts for body weight, hemoglobin deficit, and baseline iron stores.

Iron deficit (mg) = Weight (kg) × (Target Hb − Actual Hb) × 2.4 + Iron stores (mg)

  • Weight — Patient weight in kilograms (use ideal body weight for obese patients)
  • Target Hb — Target hemoglobin concentration in g/dL (12–15.5 for women, 13.5–17.5 for men)
  • Actual Hb — Current hemoglobin concentration measured by laboratory test
  • Iron stores — Baseline iron reserves; typically 500 mg or 15 mg/kg whichever is lower

Understanding Iron Deficiency Anemia

Iron deficiency anemia results from insufficient iron to produce adequate hemoglobin, the oxygen-carrying protein in red blood cells. It is the most common nutritional deficiency worldwide, affecting approximately 2% of men and 10–20% of women in developed nations, with higher prevalence in low-income countries.

Symptoms arise from tissue hypoxia and include fatigue, dyspnea on exertion, tachycardia, headache, dizziness, pallor, brittle nails, and glossitis. Severe cases may present with chest pain and syncope.

Root causes vary: chronic blood loss (gastrointestinal bleeding, heavy menstruation), malabsorption (celiac disease, inflammatory bowel disease), inadequate dietary intake, or increased demand (pregnancy, rapid growth). Diagnosis requires serum ferritin, serum iron, transferrin saturation, and complete blood count. Identifying the underlying etiology—through endoscopy, gynecologic evaluation, or dietary assessment—is essential before commencing iron repletion.

Oral vs. Parenteral Iron Therapy

Oral iron supplements remain first-line for mild to moderate deficiency due to low cost and simplicity. Ferrous salts (sulfate, fumarate, gluconate) are absorbed better than ferric forms. Dosing typically ranges 150–200 mg elemental iron daily in divided doses, continued for 3–6 months after hemoglobin normalizes to rebuild depleted stores.

Gastrointestinal side effects—constipation, nausea, epigastric discomfort, dark stools—limit tolerance in 10–20% of patients. Food reduces absorption; vitamin C enhances it.

Intravenous iron infusion bypasses the gut entirely, reaching target hemoglobin faster (weeks rather than months) and avoiding GI toxicity. Formulations include iron sucrose, iron dextran, and ferric carboxymaltose. Indications include intolerance to oral therapy, severe anemia requiring urgent repletion, or malabsorption. IV iron carries small risks of hypophosphatemia, anaphylaxis, and transient arthralgia but remains safer than transfusion in non-emergent settings.

Clinical Pearls and Common Pitfalls

Accurate iron deficit calculation requires attention to several practical considerations.

  1. Use ideal body weight correctly — Many clinicians forget to adjust weight for overweight patients. The Ganzoni equation assumes normal body composition; using actual weight in obese patients inflates the calculated deficit and may lead to iron overload. Calculate BMI or use standardized ideal weight tables.
  2. Verify hemoglobin units consistently — Some labs report hemoglobin in g/dL (US, UK) while others use mmol/L (Europe). The calculator accepts both, but manual verification prevents transcription errors. Confirm units with the originating laboratory before inputting results.
  3. Account for iron stores replacement — The equation includes a fixed 500 mg (or 15 mg/kg) for iron stores replenishment—this is not the patient's current ferritin level. Ferritin is an acute-phase reactant and unreliable during inflammation. The formula assumes you're restoring normal depot iron regardless of baseline.
  4. Plan follow-up testing — Repeat hemoglobin measurement 2–4 weeks after starting therapy to assess response. Oral iron absorption varies; if hemoglobin rises <1 g/dL after 4 weeks, consider adherence issues, ongoing blood loss, or malabsorption requiring IV therapy instead.

Frequently Asked Questions

What is the Ganzoni formula and why do doctors use it?

The Ganzoni equation calculates total iron replacement needed to correct anemia and restore iron stores. Developed in 1970, it remains the clinical standard because it accounts for three factors: the body's blood volume (7% of weight), hemoglobin iron content (0.34%), and baseline storage iron (500 mg). Unlike simpler formulas, it prevents both under-treatment (persistent anemia) and over-treatment (hemochromatosis risk). Most guidelines, including those from the American College of Gastroenterology and European Society of Hematology, recommend Ganzoni for calculating IV iron doses.

How do I know whether my patient needs oral or intravenous iron?

Start with oral iron if the deficit is <1000 mg, hemoglobin is >7 g/dL, and the patient can tolerate gastrointestinal side effects. Switch to IV iron if the patient has severe anemia (Hb <7 g/dL), significant ongoing blood loss, documented intolerance to oral iron after 2–4 weeks, malabsorption disorders (celiac disease, IBD), or requires rapid repletion for pregnancy or surgery. IV iron also suits patients with CKD on hemodialysis, as they need frequent dosing and cannot absorb oral iron reliably.

Should I use actual or ideal body weight in the calculator?

For overweight and obese patients (BMI >25), use ideal body weight derived from height-based nomograms or BMI calculators set to BMI = 22. The Ganzoni equation assumes normal body composition; excess fat tissue does not contain extra blood volume or hemoglobin iron. For underweight patients (BMI <18.5), use actual weight because they lack excess adipose tissue. This distinction prevents significantly over-calculating iron need in obese patients, which could cause hemochromatosis.

What hemoglobin target should I use for different patient groups?

Standard targets are 12–15.5 g/dL for women and 13.5–17.5 g/dL for men. However, targets vary by clinical context: elderly patients with cardiac disease may benefit from slightly lower targets (11–12 g/dL) to avoid volume overload; pregnant women need higher targets (>11 g/dL third trimester); and patients with chronic kidney disease may target 10–11 g/dL per current KDIGO guidelines. Discuss target goals with the patient and adjust for comorbidities and symptoms rather than treating to a fixed number.

How long does oral iron supplementation take to work?

Oral iron raises hemoglobin by approximately 1–2 g/dL per month if tolerated and absorbed well. Most patients require 3–6 months of therapy: 1–2 months to correct anemia, then an additional 2–4 months to replenish iron stores. Vitamin C enhances absorption, while phytates, tannins, and calcium reduce it. If hemoglobin does not rise by at least 1 g/dL after 4 weeks, investigate non-adherence, persistent bleeding, or malabsorption before switching to IV iron.

What causes iron deficiency anemia and should I screen for hidden bleeding?

The most common causes are chronic blood loss (gastrointestinal bleeding, heavy menstrual bleeding), inadequate dietary intake (vegans, poverty, anorexia), malabsorption (celiac disease, post-gastrectomy, H. pylori), and increased demand (pregnancy, lactation). Always identify the source; treating iron deficiency without addressing underlying bleeding allows the condition to recur. In men and postmenopausal women, any iron deficiency warrants upper and lower endoscopy to exclude malignancy or chronic GI bleeding. In premenopausal women with heavy periods, gynecologic evaluation and possible ultrasound are appropriate before invasive testing.

More health calculators (see all)

GAD-7 Calculator Navy PRT Calculator Exclusive Pumping Calculator Simple Calorie Intake Calculator Birth Control Cost Calculator Drug Half-Life Calculator 4Ts Score Calculator Warsaw Method Calculator